Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Formed in 2017, Carus Animal Health is a UK-based business backed by Japan's largest animal health firm Kyoritsu Seiyaku. The new company has a mandate to stimulate innovation. Animal Pharm editor Joseph Harvey met Carus to explore its strategy for addressing unmet needs.
The head of AquaBounty Technologies claims Canadian customers are very pleased with the company's genetically engineered (GE) salmon and says he hopes to begin producing the fish at a US facility by the end of the year.
VakSea is in discussions with animal health companies concerning field trials in Asia of its natural immune-boosting protein derived from insect larva.
Countries across western Europe are urging pig producers to be on heightened alert for African swine fever (ASF) after the disease surfaced in Belgium for the first time in more than 30 years.
Belgian authorities have confirmed an outbreak of African swine fever (ASF), which is the first time the country has been struck by the disease since 1985.
Royal DSM and Novozymes have launched a new feed additive that removes bacterial debris with the aim of improving feed efficiency and digestibility in broiler chickens.
In this latest Animal Pharm podcast, editor Joseph Harvey finds out how addressing the microbiome is changing the way the animal health industry approaches R&D. To understand the potential of microbiome products, he spoke to Oliver Hardcastle – the chief executive of new firm Anizome.
Polish firm Proteon Pharmaceuticals is moving into the commercial phase of development, as it takes its bacteriophage products to market.
A team from the UK's Pirbright Institute are filing a patent for a newly-developed peste de petit ruminants (PPR) vaccine, which they used as part of a program in India.
Much-needed innovation is on the way in aquaculture, with the industry now working towards a 360-degree approach to unmet needs.
A market analyst believes China's recent outbreaks of African swine fever (ASF) is not yet a large-scale epidemic.
US firm KnipBio has successfully completed a feed efficacy trial on Atlantic salmon, marking the third version of its single-cell protein to pass quality and efficacy trials.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.